Biopsy-proven lupus nephritis (LN) may be an affair of the heart as much as of the kidneys, according to a study recently published in the Journal of Rheumatology. More »
High anti–cyclic citrullinated peptide (anti-CCP) antibody levels are associated with lung disease in patients with rheumatoid arthritis (RA). Male sex is another independent risk factor for co-occurrence of active lung disease in RA. More »
Inflammation early in the rheumatoid arthritis (RA) disease course is associated with 2 measures of arterial stiffness, increased pulse-wave velocity (PWV) and augmentation index (AIx), after 15 years. Early, active disease management to control inflammation in patients with RA may help reduce the... More »
A new treatment for a disabling hand condition—Dupuytren disease, or Dupuytren contracture—can restore a person’s ability to perform everyday tasks, according to Hands: Strategies for Strong, Pain-Free Hands, a new edition of the Special Health Report from Harvard Medical School. The report... More »
Treatment for systemic lupus erythematosus (SLE) with both immunosuppressive agents and prednisone is given to patients who have the most active disease, but the presence of cumulative damage also may predict use of these agents, particularly early in the disease course. More »
The concept of psoriatic arthritis (PsA) has evolved from that of a relatively obscure mild joint disease to that of a severe inflammatory arthritis involving bones, joints, and the surrounding tissue. More »
Less complex disease activity measures for evaluating patients with rheumatoid arthritis (RA) correlate well with the C-reactive protein–based Disease Activity Score 28 (DAS28-CRP4) and may provide physicians in office practices with practical, easy-to-use tools. More »
Chronic kidney disease (CKD) has become a burgeoning epidemic. Patients with various stages of CKD initially seek care from... 